To lend further support to this hypothesis, a correlation between down regulation of claudin 1 and disease recurrence was also reported in a study involving 83 patients (57 patients with non-recurrent breast cancer and 26 patients with recurrent disease) [61]. This evidence concerns the gene CLDN1 and breast carcinoma.